XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (31,943) $ (2,013)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 2,359 3,307
Non-cash loan amortization expense 61 68
Share-based compensation expense 1,061 988
Goodwill impairment 25,700 0
Write-off of intangible assets 0 128
Provision for bad debt (55) 81
Deferred income taxes 0 0
Changes in assets and liabilities, net of business acquisitions:    
Accounts receivable 6,460 5,127
Prepaid expenses and other current assets (2,082) 451
Other non-current assets 82 (13)
Operating lease assets and liabilities, net (82) (42)
Accounts payable 6,739 (3,348)
Accrued expenses and other current liabilities (3,362) (6,251)
Deferred revenue (9) (174)
Other (39) (85)
Net cash provided by (used in) operating activities 4,890 (1,776)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capitalized costs included in intangible assets (1,134) (1,071)
Business acquisitions, net of cash acquired (1,250) (971)
Acquisition of property and equipment (7)
Net cash used in investing activities (2,384) (2,049)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments of long-term debt (1,250) (1,250)
Taxes paid related to net share settlement of vesting of restricted stock units (236) (448)
Net cash used in financing activities (1,486) (1,698)
Net increase (decrease) in cash, cash equivalents and restricted cash 1,020 (5,523)
Cash, cash equivalents and restricted cash at beginning of period 25,547 34,467
Cash, cash equivalents and restricted cash at end of period 26,567 28,944
SUPPLEMENTAL DISCLOSURE INFORMATION    
Cash paid for interest 664 301
Cash paid for income taxes 55 34
Share-based compensation capitalized in intangible assets 27 27
Liability incurred for future contingent payments in connection with TAPP consolidation 2,693 0
Liability incurred for deferred payment in connection with True North acquisition 0 860
Contingent consideration in connection with True North acquisition 0 250
Equity issued in connection with True North acquisition $ 0 $ 211